Active Ingredient: TAZEMETOSTAT HYDROBROMIDE
Proprietary Name: TAZVERIK
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 200MG BASE
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N211723
Product Number: 001
Approval Date: Jan 23, 2020
Applicant Holder Full Name: EPIZYME INC
Marketing Status:
Prescription
Patent and Exclusivity Information